Gareth Williams

Research activity per year

2021
Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Grand, D. L., Gosling, M., Baettig, U., Bahra, P., Bala, K., Brocklehurst, C., Budd, E., Butler, R., Cheung, A. K., Choudhury, H., Collingwood, S. P., Cox, B., Danahay, H., Edwards, L., Everatt, B., Glaenzel, U., Glotin, A-L., Groot-Kormelink, P., Hall, E., Hatto, J., & 24 othersHowsham, C., Hughes, G., King, A., Koehler, J., Kulkarni, S., Lightfoot, M., Nicholls, I., Page, C., Pergl-Wilson, G., Popa, M. O., Robinson, R., Rowlands, D., Sharp, T., Spendiff, M., Stanley, E., Steward, O., Taylor, R. J., Tranter, P., Wagner, T., Watson, H., Williams, G., Wright, P., Young, A. & Sandham, D. A., 10 Jun 2021, In: Journal of Medicinal Chemistry. 64, 11, p. 7241-7260 20 p.
Research output: Contribution to journal › Article › peer-review
19 Citations (Scopus)

Research output